Summary:
- Atomera Incorporated partners with a key equipment provider to boost MST technology licensing and production.
- Despite rising R&D expenses leading to a Q1 2025 net loss, the company eyes potential revenue between $0 and $50,000 for Q2 2025.
- Analysts show optimism with a 38.07% implied upside in stock price, rated as "Outperform."
Atomera Incorporated (ATOM, Financial) is making strategic strides by collaborating with a top-tier capital equipment provider. This partnership aims to fast-track the licensing and production of Atomera's MST technology, concentrating on cutting-edge nodes and gate-all-around architectures. While the company reported a net loss of $5.2 million in Q1 2025 due to escalated R&D expenditures, it projects a revenue range from $0 to $50,000 for Q2 2025.
Analysts' Price Projections
Wall Street analysts provide a one-year price target for Atomera Inc (ATOM, Financial), with an average target price set at $7.00. Both high and low estimates align at $7.00. This target suggests a promising 38.07% upside from the current stock price of $5.07. For more in-depth projections, review the detailed Atomera Inc (ATOM) Forecast page.
Brokerage Recommendations
The consensus from one brokerage firm rates Atomera Inc (ATOM, Financial) with an average brokerage recommendation of 2.0, signifying an "Outperform" status. This rating is derived from a scale where 1 represents a Strong Buy, and 5 indicates a Sell. Such a recommendation underscores a positive outlook for investors considering Atomera's market position.
